Since the start of the decade, Eli Lilly has committed to spend more than $50 billion to bolster its United States manufacturing capabilities. But even that’s not enough to meet the needs of the ...

The U.S. national debt crossed 100 percent of gross domestic product (GDP) at the end of March, with signs that it might cross the record of 106 percent of GDP reached immediately after World War II.

Eli Lilly LLY is set to release its first-quarter 2026 earnings report on April 30. Here’s Morningstar’s take on what to look for in Lilly’s earnings and the outlook for its stock. With its 3-star ...

Stock prices are not measurements of expensiveness. Companies that compound earnings over decades naturally trade at high per-share prices if they've avoided stock splits or paid significant dividends ...

EXCLUSIVE: Andria Spring has joined Hammerstone Studios (By Any Means, At the Sea) as SVP Post-Production. Specializing in post-production, finance, and overall project management, Spring comes to ...

Eli Lilly (LLY) on Monday announced an agreement to acquire Kelonia Therapeutics, a privately held cancer drug developer, in a deal worth up to $7B in cash, confirming a prior report from The Wall ...

Eli Lilly’s LLY-0.00%increase; green up pointing triangle late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results. Achieve-4, the longest phase 3 ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...

Eli Lilly & Co.’s Zepbound is helping to solve one of the most intractable health challenges of our time: obesity. Now, the drugmaker is taking on another significant public health predicament: sleep ...

A popular cocktail lounge and venue in Central Texas is closing its doors after less than two years in business. Tiger Lilly in downtown Austin announced on social media that its last day of ...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. By Rebecca Robbins Eli Lilly reached a deal on Tuesday to buy Centessa ...